A major obstacle for the widespread use of drugs to manage cardiac arrhythmias has been the relatively high incidence of extracardiac side effects. The common cardiac side effects of antiarrhythmic drugs include the depressed contractile performance, bradycardia, an altered efficacy of pacing and defibrillating devices, and the occurrence of new arrhythmias or the increased occurrence of arrhythmias. 4) The shape and duration of cardiac action potentials will vary depending on the region of the heart where they are recorded. These regional differences result, in part, from the differential expression of K ϩ channel genes within the myocardium. 5) It is well known that various K ϩ channels regulate the action potential duration and K ϩ channel genes are differentially expressed depending on the regions of the heart. K ϩ currents in the myocardium can be classified into two categories: 1) K ϩ currents such as I K1 (the inward rectifying K ϩ current), I KACh (the acetylcholine-activated K ϩ current), and I KATP (the ATPsensitive K ϩ current) and 2) the voltage-gated K ϩ (Kv) currents. 6) These Kv channels contribute to cellular repolarization, and they regulate the action potential duration. It is known that clinically, the repolarization disorders in the damaged tissues result in cardiac arrhythmias. Accordingly, Kv channels have become the major targets for the treatment of arrhythmias. The hKv1.5 channel is known to have the same electrophysiological and pharmacological properties as the I KUR channel, a current specific for the human atrium. 7) Thus the hKv1.5 channel is thought to be a unique target for atrial fibrillation.
In the present study, we did an investigation and found out that oxypeucedanin, one of the extracts from Angelica dahurica, blocked the hKv1.5 channel current that is expressed in Ltk Ϫ cells in a concentration, time and voltagedependent manner. Furthermore, we discovered that oxypeucedanin prolonged the APD of rat atrial and ventricular muscles in a dose-dependent manner. All the   1   H-and   13 C-NMR spectra were determined on a JEOL JMN-EX 400 spectrometer. The TLC was carried out on precoated silica gel F 254 plates (Merck, Darmstadt, Germany), and the silica gel for column chromatography was Kiesel gel 60 (230-400 mesh, Merck). The column used for LPLC was the Lobar A (Merck Lichroprep Si 60, 240-10 mm). All the other chemicals and solvents were of analytical grade, and they were used without further purification.
MATERIALS AND METHODS

General Procedure
Plant Materials The roots of Angelica dahurica were collected in October 2000 at Sunchang, Chonbuk, Korea. A voucher specimen was deposited in the herbarium of the college of pharmacy of Woosuk University (WSU-00-010).
Extraction and Isolation The air-dried plant materials (500 g) were ground to a fine powder and extracted twice with hot methanol under a reflux condition. The resultant methanolic extract (120 g) was chromatographed on a silica gel column using a mixture of n-hexane-ethanol-methanol with an increasing polarity, and the results yielded fifteen fractions. The third fraction demonstrated the most significant hKv1.5 current inhibitory activity. Silica gel column chromatography of the third fraction with a solvent gradient of ethanol in n-hexane yielded five subfractions. After performing the activity testing, the fifth subfraction was applied over silica gel, and it was eluted with n-hexane-ethanolmethanol (5 : 1 : 1) and purified by using a Lobar-A column (n-hexane : ethanol, 1 : 1) to yield the compound 1 (Fig. 1 
Cell Isolation and Transfection
To prepare the rat atrial and ventricular muscles, the heart of a rat was rapidly excised and then transferred to a dissection bath filled with Tyrode's solution oxygenated with a 97% oxygen and 3% carbon dioxide mixture. The atrial and ventricular muscles were carefully dissected and mounted horizontally in a narrow channel of a tissue chamber, and they were continuously superfused with oxygenated Tyrode's solution at 37°C. The mural end of those muscles was fixed with an insect pin to the bottom of the chamber coated with Sylgard. The portion of the muscles adjacent to the insect pin was pressed against the floor by stimulating electrodes, and these electrodes were used to elicit action potentials and contractions.
The method used to establish the hKv1.5 or HERG channel expression in a clonal mouse Ltk Ϫ cell line or human embryonic kidney (HEK)-293 cell line is the same as that described previously. 9, 10) The transfected cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% horse serum and 0.25 mg/ml of G418, under a 5% CO 2 atmosphere. Before the experiment the subconfluent cultures were incubated with 2 mM dexamethasone for 12 h to induce the expression of the hKv1.5 channels. The cells were removed from the dish with a rubber policeman, a procedure that left the majority of the cells intact.
Electrical Recordings The action potentials were elicited by stimulating the cardiac cells with square pulses (1 Hz, lasting 1 ms, 20-30% above threshold voltage) by a stimulator via a stimulus isolation unit (WPI, Sarasota, FL, U.S.A.). The action potentials were recorded with a 3-M KClfilled microelectrode (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) connected to an amplifier (KS-700, WPI), and they were displayed on an oscilloscope (dual-beam storage 5113, Tektronix, Beaverton, OR, U.S.A.). The tracings on the oscilloscope screen were photographed using 35-mm film, and they also recorded on a chart recorder (RS 3400, Gould, Cleveland, OH, U.S.A.). The rat atrial and ventricular muscles were superfused with Tyrode's solution at a constant rate (5 ml/min). Tyrode's solution contained 137 mM NaCl, 5.4 mM KCl, 1.05 mM MgCl 2 , 0.45 mM NaH 2 PO 4 , 11.9 mM NaHCO 3 , 1.8 mM CaCl 2 , and 5 mM dextrose.
The currents of the hKv1.5 channels were recorded by using the whole-cell configuration of the gigaohm-seal patch clamp technique. The electrical signals were amplified with a patch clamp amplifier (Axopatch-1D, Axon Instruments, Foster, U.S.A.). The currents were digitized by a signal converter (Digidata 1200, Axon Instruments) and stored on the hard disk of a computer. A micropipette (Kimax-51, 1.5-1.8ϫ10 mm) was pulled out by a 2-stage pipette puller (PP-83, Narishige, Tokyo, Japan), and it had resistance of 1-2 MW. The intracellular pipette solution for the whole cell mode contained 100 mM KCl, 10 mM HEPES, 5 mM K 4 BAPTA, 5 mM K 2 ATP and 1 mM MgCl 2 (pH 7.2). The extracellular bath solution contained 130 mM NaCl, 4 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES and 10 mM glucose (pH 7.35).
Statistical Analysis The results are expressed as meansϮS.E.M. The student's t-test and analysis of variance (ANOVA) were used to calculate the statistical significance. Value of pϽ0.05 was considered as statistically significant. Figure 2 shows the concentration-dependent inhibitory effects of oxypeucedanin on the hKv1.5 channel currents expressed in the Ltk Ϫ cells. The membrane potentials were held at Ϫ80 mV and 250-ms depolarizing pulses from Ϫ80 to ϩ60 mV in 10 mV steps were applied every 20 s. The outward currents were followed by decaying outward tail currents upon repolarization to Ϫ50 mV. Under control conditions, depolarization positive to Ϫ40 mV elicited the outward currents that progressively increased with further depolarizations. The activation time constant was 1.4Ϯ0.1 ms at ϩ60 mV (nϭ7). At ϩ60 mV, after the current reached the maximum, it slowly declined during the maintained depolarization (Fig. 2Aa) . The outward tail currents exhibited a dominant time constant of deactivation of 26.7Ϯ3.2 ms (nϭ7), as has been described previously. 9) In the presence of oxypeucedanin (1 mM), the inhibition of the hKv1.5 currents was characterized by acceleration in the current decay with relatively fewer effects on the peak amplitude (Fig. 2Ab) . Figure 2B shows the effect of oxypeucedanin (1 mM) on the steady-state current-voltage (I-V) relationship for the hKv1.5 channels constructed by plotting the current amplitudes at the end of the 250-ms depolarizations as a function of the test pulse voltage. Oxypeucedanin reduced the peak current and the steady-state current elicited by the pulses to ϩ60 mV (nϭ7). The block of the hKv1.5 currents by oxypeucedanin in a concentrationdependent manner is shown in Fig. 2C . The half-maximal inhibitory concentration (IC 50 ) and the Hill coefficient are 76.12Ϯ8.07 nM and 1.04Ϯ0.07, respectively (nϭ7).
RESULTS
To quantify the voltage dependence of oxypeucedanin block, the relative current I oxypeucedanin /I control was plotted as a function of the membrane potential (Fig. 3, nϭ5) . The blockade increased steeply between Ϫ40 and 0 mV, which corresponds to the voltage range of channel's opening.
10) The inhibition of hKv1.5 channels by 100 nM oxypeucedanin in the range of voltages between 0 and Ϫ60 mV, where the channels are fully activated, 10) showed a weak voltage-dependent decrease but it was not statistically significant.
Also, we quantified the deactivation kinetics. In the presence of oxypeucedanin (100 nM), the initial tail current was reduced and the subsequent slower decline resulted in a "crossover" phenomenon with the control tracing (Fig. 4) . These data suggest that oxypeucedanin primarily binds to the open state of the hKv1.5 channel. Figure 5 shows the effect of oxypeucedanin on the APD in the rat atrial and ventricular muscles. Oxypeucedanin prolonged the APD of the atrial and ventricular myocytes in a concentration-dependent manner.
DISCUSSION
The mammalian Kv channels are divided into nine subfamilies, Kv1-Kv9. Among them, the Kv1 subfamily is the most diverse one, and includes at least eight subclasses, Kv1.1-Kv1.8.
11) Kv1.1, Kv1.2, Kv1.4, Kv1.5, Kv2.1, Kv4.2 and Kv4.3 of the Kv channel genes have been cloned from cardiac tissue.
12) The main Kv channel genes expressed in the human heart are the hKv1.4, hKv1.5, hKv4.3 and HERG genes. All these genes are highly expressed in both the atrium and ventricle, whereas the hKv1.5 gene is preferentially expressed in the human atrium. Furthermore, the electrophysiological and pharmacological characteristics of the current generated by hKv1.5 channels are similar to the I KUR recorded in human atrial myocytes 7) and in the dog ventricle. 13) Block of the cardiac K ϩ channels increases the action potential duration. 14, 15) Thus, a selective blocker of the hKv1.5 channels that is dominantly expressed in human atrial myocytes results in a significant prolongation of the atrial action potential 16) and this could indirectly affect the heart rate: therefore, this would be an ideal antiarrhythmic drug specific for atrial fibrillation. In the present study, oxypeucedanin prolonged the APD of rat atrial and ventricu- lar muscles (Fig. 5 ) in a concentration-dependent manner, which is one of the important features of class III antiarrhythmic drugs. However, as shown in Fig. 6 , 1 mM oxypeucedanin had no effect on HERG channel, which involves in prolongation of ventricular APD resulting in long QT/Torsades de Pointes syndrome. Although we did not test the effect of oxypeucedanin on APD in human ventricular muscle, the results in Fig. 6 suggest indirectly that oxypeucedanin might not produce the prolongation of ventricular APD in human ventricle. Thus, oxypeucedanin might be better than the known antiarrhythmic drugs, because the drug might not have the risk of Torsades de Pointes.
It has been well known that hKv1.5 channels are predominantly expressed in atria. However, there are several reports suggesting that Kv1.5 channel is expressed in both rat atrial and ventricular myocyte. [17] [18] [19] Thus, although we did not do experiment with human heart due to the difficulty to get its sample, the effect of oxypeucedanin on human heart might be the same with that on rat heart.
Oxypeucedanin induced an initial fast decline of the hKv1.5 current during a depolarization (Fig. 2Ab) , suggesting that oxypeucedanin binds to the open state of hKv1.5 channels. Also, the interaction of oxypeucedanin with the hKv1.5 channels was highly voltage-dependent in the voltage range of the channel's opening (Fig. 3) . Furthermore, oxypeucedanin slowed the time course of deactivating tail currents, thus inducing the tail crossover phenomenon, which is typically detected for the open channel blocks 9, 20) (Fig. 4) . When taking these results of the APD prolongation and an open channel blockade of hKv1.5 together, oxypeucedanin could be an ideal antiarrhythmic drug for atrial fibrillation. Vol. 28, No. 4 
